Figure 1. Recovery of N0 2 ' after deproteination of serum. 190 IJ.L of the indicated concentrations of NaN0 2 in water (0, 1.56,3.13,6.25, 12.5,25,50 and 100 IJ.M) were incubated with 10 IJ.L of normal rabbit serum and then deproteinated (filled circles , solid line). Control samples contained the same concentrations of NaN0 2 and ZnS04, but did not contain serum and were not deproteinated (open squares, dashed line) . After centrifugation of all the samples, the supernatants wer e assayed for N0 2 ' by the Gries s assay. Each point represents the mean ±standard error of three separate experiments. Lines represent a linear regression analy sis of recovered N0 2 ' vs. input N0 2 ' either with or without added serum.
serum . Furthermore, toxicity is reduced since granulated Cd instead of Cd shavings is used.
Normal rat serum was obtained from Life Technologies (Gaithersburg, MD, USA) . Alternatively, C57BLl6J x SV129 mice (6) were sacrificed and blood obtained by cardiac puncture. Following a 30-min incubation on ice, the blood samples were centrifuged and the supernatant (serum) was removed for further proce ssing . To reduce N0 3 - to N0 2 -, Cd filings (0.4-0.7 g/filing; Fluka Chemical, Ronkonkoma, NY, USA) , one per sample to be assayed, were placed into 1.5-mL Eppendorf® microcentrifuge tubes (Brinkmann Instruments, Westbury, NY, USA) . The filings were washed as follows : water (2x 1 mL) ; 0.1 M HCl (2x 1 mL); 0.1 M ammonium hydroxide, pH 9.6 (2x 1 mL). Between washes , the samples were vortex mixed and rotated endover-end for 10 min, and each Cd filing was distributed to a separate microcentrifuge tube . Each serum sample 120 100 80 60 (10-50 IJ-L) was brought up to 200 IJ-L with water, and then 10 IJ-L of 30% (wt/vol) ZnS04 solution were added. The samples were vortex mixed, incubated at room temperature for 15 min and centrifuged for 5 min. The resulting supernatants were added to the Cdcontaining microcentrifuge tubes and incubated at room temperature for overnight, rotating end-over-end. The samples were transferred to fresh microcentrifuge tubes and centrifuged again. 'The supernatants were subsequently assayed for N0 2 ' + N0 3 -content. Nitrite was measured by the Griess assay (3, 4, 11, 12) . Briefly, 100 IJ-L Griess reagent (1% sulfanilamide/0.1 % naphthylethylenediamine dihydrochloridel2.5% H 3P04; Sigma Chemical, St. Louis, MO, USA) were added to 100 IJ-L of each of the above supernatants. The plates were read using a Vmax" microplate reader (Molecular Devices, Sunnyvale, CA, USA) at 550 nm against a standard curve of Nitric oxide (NO) is produced in mammalian cells by one of three broad classes of nitric oxide synthase (NOS) (10). Large amounts of NO are generated by the cytokine-inducible isoform of NO synthase (iNOS) and have been implicated in cytotoxicity or cytostasis of activated macrophages toward parasites and tumors, in the patho logy of septic shock, and in the suppression of cardiac function (10). Thus , assaying NO rapidly and efficiently in various fluids is of critical importance. High-output NO production by cells or its accumulation in biological solutions has been assayed in various ways (1-5,7-9,11). The simplest assay methods for relatively large amounts of NO in biological fluids have relied on the reaction of NO in aqueous solutions to form nitrite (N0 2 -) and nitrate (N0 3 -) (1, 3, 4, 9, 11) . In urine and plasma, NO is found primarily as N0 3 -, but N0 2 -can be assayed more easily by colorimetric diazotization (Griess reaction; References 1, 3, 4 and 11). Upon reduction with metallic cadmium (Cd) (3,4,11), or enzymatically by means of bacterial nitrate reductase (1,2), N0 3 ' is converted to N0 2 -and can then be detected by the Griess reaction.
Quantitation of N0 2 -and N0 3 -in serum using bacterial nitrate reductase followed by the Griess reaction can be expensive and requires standardization of different batches of the enzyme (2). As currently implemented, reduction on Cd is cumbersome and time-consuming for many samples and may involve complex apparatus setup, as is the case with semi-automated nitrate analyzers (3). The method for Cd-mediated reduction of N0 3 -to N0 2 -described by Hegesh and Shiloah (4) and Shi et al. (11) is inexpensive, but require s packing of toxic Cd shavings into columns, thus necessitating sample volumes greater than 100 IJ-L. This report describes a modification of these protocols that is suitable for rapid, quantitative and inexpensive determination of serum N0 2 -and N0 3 -in samples containing as little as 10 IJ-L of
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Benchmarks the NO z-+ N0 3 -content of water, and the recovery ofNO z -was calculated.
Previous reports have stated that NO in serum and urine is present predominantly as N0 3 -, not as NO z ' (3) . In accordance with this observation, no NO z -was detected in normal rat serum samples prior to reduction by Cd (data not shown). The next parameter tested was whether addition of serum and deproteination affected the recovery of Vol. ZO, No . 3 (1996 ) an inhibitor of NOS activity (13) . This modification of the Cd-mediated reduction of N0 3 -to N0 2 -is accurate, reproducible and also rapid, as many samples can be assayed simultaneously. It does not requiresophisticated apparatus or relatively large sample volumes. Finally, since granulated Cd instead of fine Cd shavings are used, there is a lower likelihood of inhaling small particles of Cd and thus a potentially lower toxicity to the researcher. As the study of NO and its physiologic and pathophysiologic effects develops, a quick, easy and inexpensive assay for serum NO levels is needed. The assay described herein should facilitate these studies .
